Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis
Autor: | Maurizio Raiteri, Luca Raiteri, Simona Zappettini, Giambattista Bonanno, Silvio Paluzzi, Sara Stigliani |
---|---|
Rok vydání: | 2005 |
Předmět: |
medicine.medical_specialty
GABA Plasma Membrane Transport Proteins animal structures DNA Complementary animal diseases SOD1 Excitotoxicity Glutamic Acid Mice Transgenic Toxicology medicine.disease_cause chemistry.chemical_compound Mice Superoxide Dismutase-1 Glycine Plasma Membrane Transport Proteins Internal medicine medicine GABA transporter Animals Humans biology Amyotrophic lateral sclerosisSOD1-G93A(+) miceGlutamate releaseGlycine heterotransportersGABA heterotransportersRelease mechanisms Superoxide Dismutase General Neuroscience Amyotrophic Lateral Sclerosis Glutamate receptor nutritional and metabolic diseases Long-term potentiation Strychnine GABA receptor antagonist nervous system diseases Endocrinology nervous system Biochemistry chemistry Spinal Cord Glycine biology.protein Algorithms Synaptosomes |
Zdroj: | Neurotoxicology. 26(5) |
ISSN: | 0161-813X |
Popis: | Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease, involving both upper and lower motor neurons, the cause of which is obscure, although glutamate (GLU)-induced excitotoxicity has been suggested to play a major role. We studied the release of [3H]d-aspartate ([3H]d-ASP) and endogenous glutamate evoked by glycine (GLY) or GABA from spinal cord synaptosomes in mice expressing a mutant form of human SOD1 with a Gly93Ala substitution ([SOD1-G93A(+)]), a transgenic model of amyotrophic lateral sclerosis, in mice expressing the non-mutated form of human SOD1 [SOD1+], and in non-transgenic littermates [SOD1(-)/G93A(-)]. In parallel experiments, we also studied the release of [3H]GABA evoked by GLY and that of [3H]GLY evoked by GABA. Mutant mice were killed at advanced phase of pathology or during the pre-symptomatic period. In SOD1(-)/G93A(-) or SOD1(+) mice GLY evoked [3H]d-ASP and [3H]GABA release, while GABA caused [3H]d-ASP, but not [3H]GLY, release. The GLY-evoked release of [3H]d-ASP, but not that of [3H]GABA, and the GABA-evoked [3H]d-ASP release, but not that of [3H]GLY, were more pronounced in SOD1-G93A(+) than in SOD1(+) or SOD1(-)/G93A(-) mice. Furthermore, the excessive potentiation of [3H]d-ASP by GLY or GABA was already present in asymptomatic 30-40 day-old SOD1-G93A(+) mice. The releases of endogenous glutamate and GABA also were enhanced by GLY and the GLY-evoked release of endogenous glutamate, but not of endogenous GABA, was higher in SOD1-G93A(+) than in control animals. Potentiation of the spontaneous amino acid release is likely to be mediated by activation of a GLY or a GABA transporter, since the effect of GLY was counteracted by the GLY transporter blocker glycyldodecylamide but not by the GLY receptor antagonists strychnine and 5,7-dichlorokynurenate while the effect of GABA was diminished by the GABA transporter blocker SKF89976-A but not by the GABA receptor antagonists SR9531 and CGP52432. It is concluded that the glutamate release machinery seems excessively functional in SOD1-G93A(+) animals. |
Databáze: | OpenAIRE |
Externí odkaz: |